@article{5de875b9345845f297663fa4071c9624,
title = "Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression",
keywords = "BMP5, Major depression, SSRI, antidepressant, exome sequencing, pharmacogenomics",
author = "Rudolf Uher",
note = "Funding Information: This study was supported by Targeted Financing from the Estonian Government: SF0180142, the European Union through the European Regional Development Fund in the frame of Centre of Excellence in Genomics and 7 FP Project OPENGENE 245536, Estonian Research Roadmap through Estonian Ministry of Education and Research, and the Development Fund of the University of Tartu (SP1GVARENG). This project was also funded by the National Basic Research Program of China (973 program 2011CB809200) and Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A). GENDEP was funded by the European Commission Framework 6 grant, EC Contract Ref.: LSHB-CT-2003-503428. GENDEP genotyping was funded by a joint grant from the UK Medical Research Council and GlaxoSmithKline (G0701420) and the Innovative Medicine Initiative Joint Undertaking (IMI-JU) under grant agreement n° 115008, of which resources are composed of European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) in-kind contribution and financial contribution from the European Union{\textquoteright}s Seventh Framework Programme (FP7/2007-2013). Dr. Uher is supported by the Canada Research Chair program ( http://www.chairs-chaires.gc.ca/ )",
year = "2013",
month = oct,
doi = "10.1177/0269881113499829",
language = "English",
volume = "27",
pages = "915--920",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "10",
}
